3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Conditions
Carcinoma, Non-Small-Cell Lung
96
Lung Neoplasms
38
Neoplasms
10
Mesothelioma, Malignant
9
Mesothelioma
8
Adenocarcinoma of Lung
8
Small Cell Lung Carcinoma
7
Neoplasm Metastasis
7
Thoracic Neoplasms
5
Recurrence
5
Lung Diseases
5
Carcinoma
5
Respiratory Tract Neoplasms
4
Carcinoma, Bronchogenic
4
Brain Neoplasms
4
Respiratory Tract Diseases
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Neoplasms by Site
3
Neoplasms by Histologic Type
3
NSCLC
3
Head and Neck Neoplasms
3
Bronchial Neoplasms
3
Adenocarcinoma, Bronchiolo-Alveolar
3
Adenocarcinoma
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Non-small-cell Lung Cancer With Somatic EGFR Mutations
2
Neoplasms, Nerve Tissue
2
Melanoma
2
Interventions
pembrolizumab
2
Sunitinib
2
Cisplatin
2
Brentuximab Vedotin
2
tremelimumab
1
pralsetinib
1
keyhole-limpet hemocyanin
1
durvalumab
1
Tetanus Toxoid
1
Sirolimus
1
Plicamycin
1
Pemetrexed
1
Paclitaxel
1
Genistein
1
Gemcitabine
1
Gefitinib
1
Erlotinib Hydrochloride
1
Epirubicin
1
Carboplatin
1
Bevacizumab
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Neoplasms, Germ Cell and Embryonal
×
Pemetrexed
×
Clear all
NCT04222972
2026-03-05
AcceleRET-Lung
Hoffmann-La Roche
Phase 3
Terminated
223 enrolled
18 charts